 TEL AVIV, Israel, Feb. 24, 2021 GLOBE NEWSWIRE -- InspireMD, Inc. NYSE American: NSPR, developer of the CGuardTM Embolic Prevention System EPS for the prevention of stroke caused by carotid artery disease, announced today that it has engaged Hart Clinical Consultants HCC, a leading Contract Research Organization CRO to conduct the clinical trial for its CGuard Carotid Stent System in the United States. 